| # | Drug | Count |
|---|---|---|
| 0 | AFLIBERCEPT | 16 |
| 1 | FARICIMAB | 13 |
| 2 | RANIBIZUMAB | 13 |
| 3 | CARBOPLATIN | 11 |
| 4 | DOCETAXEL | 11 |
| 5 | DOCETAXEL ANHYDROUS | 11 |
| 6 | PERTUZUMAB | 11 |
| 7 | TRASTUZUMAB | 11 |
| 8 | AMLODIPINE | 8 |
| 9 | PREDNISONE | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | METRONIDAZOLE ORAL | 1 | 0.0435 |
| 1 | VORETIGENE NEPARVOVEC-RZYL | 3 | 0.0197 |
| 2 | SODIUM THIOSULFATE | 4 | 0.0071 |
| 3 | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | 7 | 0.0064 |
| 4 | PEGCETACOPLAN | 7 | 0.0037 |
| 5 | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | 1 | 0.0018 |
| 6 | TOBRAMYCIN AND DEXAMETHASONE | 5 | 0.0015 |
| 7 | FARICIMAB | 13 | 0.0015 |
| 8 | DORZOLAMIDE HCL | 1 | 0.0009 |
| 9 | PENTOSAN POLYSULFATE SODIUM | 6 | 0.0009 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antiseptic [EPC] | 1 | 0.0002 |
| 1 | Sulfone [EPC] | 2 | 0.0002 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 30 | 0.0002 |
| 3 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 4 | HER2/neu Receptor Antagonist [EPC] | 11 | 0.0001 |
| 5 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 2 | 0.0001 |
| 6 | Aminoglycoside Antibacterial [EPC] | 6 | 0.0001 |
| 7 | Complement Inhibitor [EPC] | 7 | 0.0001 |
| 8 | Antimetabolite Immunosuppressant [EPC] | 2 | 0.0001 |
| 9 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |